F-12,826

F-12,826
Nazivi
	Preferisani IUPAC naziv 2-[4-[4-(2-hidroksifenil)piperazin-1-il]butil]-4-metil-1,2,4-triazin-3,5-dion
	Drugi nazivi CHEMBL3330609 • 903528-73-4 • SCHEMBL4546516 • VFFKDKDNXHSXLX-UHFFFAOYSA-N • MFCD13182401
Identifikacija
3D model (Jmol)	interaktivna slika;
PubChem C ID	59738835;
	SMILES CN1C(=O)C=NN(C1=O)CCCCN2CCN(CC2)C3=CC=CC=C3O; ; ; ; ; ;
Svojstva
Hemijska formula	C18H25N5O3
Molarna masa	359,43 g·mol−1
	Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
	Reference infokutije

F-12,826 je agonist 5-HT1A receptora.^[3] Studije su pokazale da ligandi 5-HT1A receptora modulišu katalepsiju izazvanu antipsihoticima.

Reference

^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
^ Eric P M Prinssen; Francis C Colpaert; Wouter Koek (2002-10-25). „5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy”. Eur J Pharmacol. 453 (2-3): 217—21. doi:10.1016/s0014-2999(02)02430-5.